@MDAndersonNews/Our blood disease experts / Twitter
MD Anderson experts specializing in leukemia, lymphoma, myeloma and other blood diseases
MD Anderson experts specializing in leukemia, lymphoma, myeloma and other blood diseases
HOUSTON ― Cancer survivors and tennis legends Chris Evert and Martina Navratilova participated in a fireside-style chat on Wednesday, May 1 at The University of…
Antibody-drug conjugates are a new type of cancer therapy that deliver cancer-killing medicine to cancer cells, avoiding healthy cells along the way.
For people with no family history of colon cancer or other risk factors Swedish researchers found that screening every 15 years was still protective.
How long does it take for chemotherapy to start shrinking a tumor? Head and neck specialist and thoracic medical oncologist Janet Tu, M.D., weighs in.
Nodular melanoma is a type of skin cancer that can mimic benign conditions, including blood blisters and acne. So, how do you know when to…
Experiencing guilt after cancer treatment may sound unexpected, but it’s actually quite common. Clinical psychologist Catherine Powers, Ph.D., and senior social work counselor Kendolyn Shankle…
Researchers uncover lung adenocarcinoma’s early roots, tracing the cancer back to a specific cell type. These insights offer new hope for detection and prevention.
Did you know that drinking alcohol can affect your cancer risk, lead to long-term health issues and impact your microbiome, sleep and brain function? Our…
Dr. Trisha Amboree explains the findings of the research and how it can help mitigate health disparities.
For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer…